Change in Mindfulness in Borderline Personality Disorder

Borderline Personality Disorder Clinical Trial

Official title:

Change in Mindfulness in Borderline Personality Disorder After Dialectic-behavioural Therapy (DBT): A Pre-post-comparison

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03297840
• Other study ID #: Mindfullness in BPD
• Status: Recruiting
• Phase: N/A
• First received: May 9, 2017
• Last updated: September 26, 2017
• Start date: May 4, 2017
• Est. completion date: December 2017

Study information

• Verified date: September 2017
• Source: University of Oldenburg
• Contact: Katharina Bachmann, Psych.Msc.
• Phone: 00494119615 1506
• Email: Katharina.Bachmann[@]uni-oldenburg.de
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The current study aims to investigate the effect of dialectical behavioral therapy on mindfulness in patients with Borderline Personality Disorder. A treatment group will be compared to a waitlist control group.

Description:

Participants will be recruited from the Dialectical-Behavioral-Therapy (DBT) unit. DBT is a treatment approach that has been shown to be effective in the treatment of Borderline Personality Disorder. DBT integrates different psychotherapeutic interventions as well as Mindfulness Meditation exercises. Mindfulness is a meditation practice that can improve present moment awareness. When applied as therapeutic intervention mindfulness meditation can help patients to stay with their attention in the present moment, to be aware what is happening in the here and now, and to better identify and regulate upcoming emotions.

The current observational study investigates changes in symptom severity and mindfulness skills during DBT treatment. A treatment group will be compared to a waitlist control group. The two groups are predefined by routine medical care.

Symptom severity and mindfulness skills will be assessed at baseline (before treatment or when accepted for the waitlist) and after 12-weeks. A within and between group analyses will be performed.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 2017
• Est. primary completion date: November 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Clinical diagnosis of Borderline Personality Disorder

• On the waitlist for DBT treatment or actually treated with DBT

• Not previously treated with DBT.

Exclusion Criteria:

• Severe psychiatric comorbidity e.g. psychosis, severe depression, suicidality

Related Conditions & MeSH terms

• Borderline Personality Disorder
• Disease
• Mindfulness
• Personality Disorders

Intervention

Behavioral:
• Dialectical Behavioural Therapy (DBT)
Inpatient Dialectical Behavioural Therapy (DBT) according to Linehan.

Locations

Country	Name	City	State
Germany	Department of Psychiatry and Psychotherapy - University Hospital, University of Oldenburg	Bad Zwischenahn

Sponsors (1)

Lead Sponsor	Collaborator
Katharina Bachmann

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in mindfulness	Degree of mindfulness will be assessed by the Kentucky Inventory of Mindfulness Skills, German Version (KIMS-D). A within and between group comparison will be performed (treatment vs. waitlist).	Baseline and after 12-weeks
Primary	Change in borderline symptom severity	Change in Borderline symptom severity is measured by the Borderline Symptom List (BSL 23). A within and between group comparison will be performed (treatment vs. waitlist).	Baseline and after 12-weeks
Primary	Change in overall psychiatric symptom severity	Change in overall symptom severity is measured by the Change in symptomseverity is measured by the Symptom-Checklist-90®-Standard (SCL-90). A within and between group comparison will be performed (treatment vs. waitlist).	Baseline and after 12-weeks
Primary	Change in severity in symptoms of depression	Change in overall symptom severity is measured by the Beck depression inventory (BDI). A within and between group comparison will be performed (treatment vs. waitlist).	Baseline and after 12-weeks